Clinical Trials in San Francisco

Showing 12001-12020 of 12,991 trials

Measuring Effectiveness in Sleep Apnea Surgery

NCT00518128

The goal of this research is to improve our understanding of the effectiveness of surgical OSA treatment by evaluating its impact on these health-related and functional outcomes and comparing these effects to the changes in respiratory physiology achieved after surgery. To achieve this goal, we will examine key health-related (C-reactive protein, homocysteine, leptin, the homeostasis model of insulin resistance, and heart rate variability) and functional (sleep-related quality of life and vigilance) measures among a surgical group of OSA patients who do not tolerate non-surgical treatment (positive airway pressure, PAP) and a comparison group of matched OSA patients who tolerate PAP.

Obstructive Sleep Apnea

University of California, San Francisco60 participantsStarted Jul 2007

San Francisco, California, United States

COMPLETEDPhase 3< 1 mile

Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain

NCT00857415

The study is designed to test the relationship between measurements of brain amyloid using florbetapir F 18 PET imaging and true levels of amyloid by dissection of the brain at autopsy. Amyloid in the brain is a key feature of Alzheimer's Disease (AD).

Alzheimer's Disease

Avid Radiopharmaceuticals226 participantsStarted Dec 2008

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Sun City, Arizona, United States +22 more locations

Measuring Effectiveness in Sleep Apnea Surgery

Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain

Find Trials by Condition in San Francisco

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine

The Use of rFVIIa in Trauma Patients: A Multi-Center Case Registry

Massage for Pediatric Oncology

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

Endoscopic Capillary Oximetry for Tumor Diagnosis in Head and Neck Cancer

Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma

Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease

FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

Dose Finding Posterolateral Thoracotomy Study

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

A Noninvasive Test for Fetal RHD Genotype

Study Evaluating The Tolerability Of Multiple Doses Of HKI-272

H1N1 Vaccine at Two Dose Levels in HIV Positive Adults